GB1567515A - Esters of testo-sterone and 5 -dihydro-testosterone - Google Patents
Esters of testo-sterone and 5 -dihydro-testosterone Download PDFInfo
- Publication number
- GB1567515A GB1567515A GB21314/77A GB2131477A GB1567515A GB 1567515 A GB1567515 A GB 1567515A GB 21314/77 A GB21314/77 A GB 21314/77A GB 2131477 A GB2131477 A GB 2131477A GB 1567515 A GB1567515 A GB 1567515A
- Authority
- GB
- United Kingdom
- Prior art keywords
- testosterone
- alkyl
- esters
- weight
- cyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/691,103 US4098802A (en) | 1975-02-18 | 1976-05-28 | Oral pharmaceutical preparation having androgenic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1567515A true GB1567515A (en) | 1980-05-14 |
Family
ID=24775172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB21314/77A Expired GB1567515A (en) | 1976-05-28 | 1977-05-20 | Esters of testo-sterone and 5 -dihydro-testosterone |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52148060A (cs) |
| AR (1) | AR214323A1 (cs) |
| BE (1) | BE855163A (cs) |
| CH (1) | CH627761A5 (cs) |
| DE (1) | DE2723876C2 (cs) |
| DK (1) | DK146096C (cs) |
| ES (1) | ES459230A1 (cs) |
| FI (1) | FI57597C (cs) |
| FR (1) | FR2352832A1 (cs) |
| GB (1) | GB1567515A (cs) |
| NL (1) | NL7705790A (cs) |
| SE (1) | SE425493B (cs) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002015938A3 (en) * | 2000-08-23 | 2002-08-15 | Akzo Nobel Nv | Testosterone ester formulation for human use |
| US7718640B2 (en) | 2003-03-14 | 2010-05-18 | Bayer-Schering Pharma Ag | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US12310978B2 (en) | 2015-06-15 | 2025-05-27 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| TW201521731A (zh) * | 2013-03-15 | 2015-06-16 | 利波辛股份有限公司 | 用於口服之脂平衡的長鏈睪固酮酯 |
| US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| JP2021531348A (ja) | 2018-07-20 | 2021-11-18 | リポシン，インク． | 肝臓病 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL189235C (nl) * | 1974-02-28 | 1993-02-16 | Akzo Nv | Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking. |
-
1977
- 1977-05-20 GB GB21314/77A patent/GB1567515A/en not_active Expired
- 1977-05-24 CH CH640477A patent/CH627761A5/de not_active IP Right Cessation
- 1977-05-25 JP JP6170477A patent/JPS52148060A/ja active Granted
- 1977-05-26 FR FR7716182A patent/FR2352832A1/fr active Granted
- 1977-05-26 FI FI771684A patent/FI57597C/fi not_active IP Right Cessation
- 1977-05-26 DE DE2723876A patent/DE2723876C2/de not_active Expired
- 1977-05-26 NL NL7705790A patent/NL7705790A/xx not_active Application Discontinuation
- 1977-05-27 BE BE178016A patent/BE855163A/xx not_active IP Right Cessation
- 1977-05-27 AR AR267807A patent/AR214323A1/es active
- 1977-05-27 ES ES459230A patent/ES459230A1/es not_active Expired
- 1977-05-27 DK DK236877A patent/DK146096C/da not_active IP Right Cessation
- 1977-05-27 SE SE7706235A patent/SE425493B/xx not_active IP Right Cessation
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002015938A3 (en) * | 2000-08-23 | 2002-08-15 | Akzo Nobel Nv | Testosterone ester formulation for human use |
| JP2004506698A (ja) * | 2000-08-23 | 2004-03-04 | アクゾ・ノベル・エヌ・ベー | ヒトに用いるためのテストステロンエステル製剤 |
| AU2001291775B2 (en) * | 2000-08-23 | 2005-09-08 | N.V. Organon | Testosterone ester formulation for human use |
| US7718640B2 (en) | 2003-03-14 | 2010-05-18 | Bayer-Schering Pharma Ag | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US8338395B2 (en) | 2003-03-14 | 2012-12-25 | Bayer Intellectual Property Gmbh | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| US9012436B2 (en) | 2008-04-28 | 2015-04-21 | Diurnal Limited | Lipid composition |
| US11311555B2 (en) | 2010-11-30 | 2022-04-26 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364249B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US11364250B2 (en) | 2010-11-30 | 2022-06-21 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US12310978B2 (en) | 2015-06-15 | 2025-05-27 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
Also Published As
| Publication number | Publication date |
|---|---|
| FI771684A7 (cs) | 1977-11-29 |
| DK146096C (da) | 1983-11-21 |
| AR214323A1 (es) | 1979-05-31 |
| BE855163A (fr) | 1977-11-28 |
| SE7706235L (sv) | 1977-11-29 |
| FR2352832A1 (fr) | 1977-12-23 |
| FI57597C (fi) | 1980-09-10 |
| FR2352832B1 (cs) | 1980-07-11 |
| ES459230A1 (es) | 1978-11-16 |
| JPS52148060A (en) | 1977-12-08 |
| DE2723876C2 (de) | 1986-10-30 |
| DK146096B (da) | 1983-06-27 |
| FI57597B (fi) | 1980-05-30 |
| CH627761A5 (en) | 1982-01-29 |
| SE425493B (sv) | 1982-10-04 |
| JPS6145637B2 (cs) | 1986-10-08 |
| DE2723876A1 (de) | 1977-12-15 |
| NL7705790A (nl) | 1977-11-30 |
| DK236877A (da) | 1977-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4083973A (en) | Pharmaceutical preparation adapted for oral administration | |
| US4071623A (en) | Pharmaceutical preparation adapted for oral administration | |
| US4147783A (en) | Oral pharmaceutical preparation | |
| US4220599A (en) | Oral pharmaceutical preparation having androgenic activity | |
| US4098802A (en) | Oral pharmaceutical preparation having androgenic activity | |
| US4078084A (en) | Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides | |
| JPS6296422A (ja) | 子宮内膜増殖症予防または治療用組成物の製造方法およびその来成物を用いる前記増殖症の予防または治療方法 | |
| GB1567515A (en) | Esters of testo-sterone and 5 -dihydro-testosterone | |
| ZA200005915B (en) | Pharmaceutical compositions capable of being gelled. | |
| IL37026A (en) | Pharmaceutical preparations containing vitamin a derivatives | |
| GB1565229A (en) | K-estrane compounds and pharmaceutical compositions containing same | |
| US4842865A (en) | Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules | |
| US4259325A (en) | 1,3-Dibenzoic acid esters of 17α-ethynyl-7α-methyl-1,3,5(10)-estratriene-1,3,17β-triol | |
| US3450821A (en) | Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof | |
| JPS60204739A (ja) | エイコサポリエン酸系化合物含有粉体 | |
| CA1113926A (en) | Pharmaceutical preparation adapted for oral administration | |
| EP0112451A2 (en) | Prostaglandin and hydroxylated fatty acid ester formulations | |
| JP2000336029A (ja) | 共役リノレン酸を有効成分とする乳癌抑制剤 | |
| US3764620A (en) | Novel azalkane prostaglandin compounds | |
| Okonkwo et al. | Fatty livers induction by orotic acid contained in skim milk powder | |
| CA1083139A (en) | Pharmaceutical preparation adapted for oral administration | |
| KR820000180B1 (ko) | 폴리엔 화합물의 제조방법 | |
| KR100263085B1 (ko) | 신규의 알카로이드 유도체, 이의 용도 및 이를 함유한 제약적 조성물 | |
| FR2566407A1 (fr) | Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant | |
| CA1127655A (en) | N-benzoyl-retinylamines, their preparation and pharmaceutical formulations containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |